Search Results - "Morrish, P K"

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET study by Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J., Brooks, D. J.

“…We have studied focal changes in dopaminergic function throughout the brain volume in early and advanced Parkinson's disease by applying statistical parametric…”
Get full text

Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET by Morrish, P K, Rakshi, J S, Bailey, D L, Sawle, G V, Brooks, D J

“…OBJECTIVES To measure the rate of progression in striatal [18F]dopa metabolism in a large group (n=32) of patients with Parkinson’s disease, to estimate the…”
Get full text

An [18F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease by Morrish, P. K., Sawle, G. V., Brooks, D. J.

“…We have studied disease progression in a group of 10 patients with recent onset idiopathic Parkinson's disease [mean age 53.7±12.6 years, mean duration…”
Get full text

Clinical and [18F] dopa PET findings in early Parkinson's disease by Morrish, P K, Sawle, G V, Brooks, D J

“…Twenty seven patients with recent onset (mean symptom duration 22 (SD 14) months, Hoehn and Yahr score 1.8 (SD 0.7)) Parkinson's disease were studied with…”
Get full text

Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease by Morrish, P. K., Sawle, G. V., Brooks, D. J.

“…We have investigated regional changes in dopamine metabolism within the basal ganglia with clinical progression of idiopathic Parkinson's disease, using…”
Get full text

REAL and CALM: What have we learned? by Morrish, P.K.

Get full text

Parkinson's disease is not a long-latency illness by Morrish, P. K.

Get full text

The harsh realities facing the use of SPECT imaging in monitoring disease progression in Parkinson’s disease by Morrish, P K

“…[...]the UPDRS scores were influenced by dopaminergic drug effects and therefore were not suitable to study correlations with [123I][beta]-CIT SPECT measures…”
Get full text

The danger of ignoring a migraine by Bajaj, N P S, Morrish, P K

“…Fundoscopy revealed the presence of arteriolar-venous nipping, "flame shaped" and "dot and blot" retinal haemorrhages, "cotton wool" spots, and papilloedema…”
Get full text

Graves' disease presenting as hemiparkinsonism by DAVIES, J. S, MORRISH, P. K, SCANLON, M. F

Get full text

The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease by Sawle, G V, Burn, D J, Morrish, P K, Lammertsma, A A, Snow, B J, Luthra, S, Osman, S, Brooks, D J

“…We used PET and [18F]-6-L-fluorodopa ([18F]dopa) to measure the effect of a peripheral COMT inhibitor, entacapone, on the extracerebral metabolism and…”
Get full text

Leukoencephalopathy associated with khat misuse by MORRISH, P K, NICOLAOU, N, BRAKKENBERG, P, SMITH, P E M

“…The leaves are also chewed by members of the Yemeni and Somali community in the United Kingdom. 1 The psychoactive constituents of khat are cathin…”
Get full text

Parkinson's disease in twins by Morrish, P K

Get full text

Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study by Piccini, P, Morrish, P K, Turjanski, N, Sawle, G V, Burn, D J, Weeks, R A, Mark, M H, Maraganore, D M, Lees, A J, Brooks, D J

“…There is increasing evidence for familial aggregation in Parkinson's disease (PD). It is possible that some asymptomatic relatives of PD patients have…”
Get more information

The rate of progression of Parkinson's disease. A longitudinal [18F]DOPA PET study by Morrish, P K, Sawle, G V, Brooks, D J

Get more information

Inadequate neurology services undermine patient care in the UK by Morrish, Paul K

“…Action is required to restore balance and ensure fair access…”
Get full text

A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET study by RAKSHI, J. S, PAVESE, N, UEMA, T, ITO, K, MORRISH, P. K, BAILEY, D. L, BROOKS, D. J

“…To study the relative rates of progression of early Parkinson's disease (PD) in patients started on a dopamine agonist, ropinirole, or L-dopa. A double-blind…”
Get full text

Preclinical diagnosis of Parkinson's disease by Horstink, M W, Morrish, P K

Get more information

Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson’s disease by Ito, K, Morrish, P K, Rakshi, J S, Uema, T, Ashburner, J, Bailey, D L, Friston, K J, Brooks, D J

“…OBJECTIVE To apply statistical parametric mapping to 18F-dopa PET data sets, to examine the regional distribution of changes in dopaminergic metabolism in…”
Get full text

Stroke and neurological illness: the real lottery by Morrish, Paul K

Get full text